Group 2 On August 1, 2022, AtrasZhinigang Manufacturing Co. received P4,200,000 from The STUVWXYZ Corporation for the development of a vaccine in a period of two years. The amount received was lodged to Deferred R & D revenue (liability method). On December 31, 2022, the company accountant prepared the covering adjusting entry to update the liability and revenue accounts Prepare the correcting entry (if any) if the adjusting entry made by the accountant on December 31, 2022 is as follow: a. Deferred R & D Revenue 2,100,000 R&D Revenue 2,100,000 b. R& D Revenue 875,000 Loss on R & D amortization 3,325,000 Deferred R & D Revenue 4,200,000 c. Deferred R & D Revenue 3,325,000 R&D Revenue 875,000 Gain on R & D 2,450,000 d. Investment in R &D 3,325,000 Deferred R & D Revenue 3,325,000 e. R& D revenue 2,100,000 Deferred R & D revenue 2,100,000 **Note: Use 24 months for the distribution of Revenue

SWFT Comprehensive Volume 2019
42nd Edition
ISBN:9780357233306
Author:Maloney
Publisher:Maloney
Chapter16: Accounting Periods And Methods
Section: Chapter Questions
Problem 29P
icon
Related questions
Question

give the solutions and explain how you come up with that answer

Group 2
On August 1, 2022, Atras-Zhinigang Manufacturing Co. received P4,200,000 from The STUVWXYZ Corporation
for the development of a vaccine in a period of two years. The amount received was lodged to Deferred R & D
revenue (liability method). On December 31, 2022, the company accountant prepared the covering adjusting
entry to update the liability and revenue accounts
Prepare the correcting entry (if any) if the adjusting entry made by the accountant on December 31, 2022
is as follow:
Deferred R & D Revenue
2,100,000
a.
R&D Revenue
2,100,000
b.
R &D Revenue
875,000
Loss on R & D amortization
3,325,000
Deferred R &D Revenue
4,200,000
Deferred R & D Revenue
3,325,000
c.
R&D Revenue
875,000
Gain on R & D
2,450,000
d. Investment in R & D
3,325,000
Deferred R & D Revenue
3,325,000
e. R&D revenue
2,100,000
Deferred R & D revenue
2,100,000
** Note: Use 24 months for the distribution of Revenue
Transcribed Image Text:Group 2 On August 1, 2022, Atras-Zhinigang Manufacturing Co. received P4,200,000 from The STUVWXYZ Corporation for the development of a vaccine in a period of two years. The amount received was lodged to Deferred R & D revenue (liability method). On December 31, 2022, the company accountant prepared the covering adjusting entry to update the liability and revenue accounts Prepare the correcting entry (if any) if the adjusting entry made by the accountant on December 31, 2022 is as follow: Deferred R & D Revenue 2,100,000 a. R&D Revenue 2,100,000 b. R &D Revenue 875,000 Loss on R & D amortization 3,325,000 Deferred R &D Revenue 4,200,000 Deferred R & D Revenue 3,325,000 c. R&D Revenue 875,000 Gain on R & D 2,450,000 d. Investment in R & D 3,325,000 Deferred R & D Revenue 3,325,000 e. R&D revenue 2,100,000 Deferred R & D revenue 2,100,000 ** Note: Use 24 months for the distribution of Revenue
Expert Solution
steps

Step by step

Solved in 2 steps with 3 images

Blurred answer
Knowledge Booster
Accounting Principles
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, accounting and related others by exploring similar questions and additional content below.
Similar questions
  • SEE MORE QUESTIONS
Recommended textbooks for you
SWFT Comprehensive Volume 2019
SWFT Comprehensive Volume 2019
Accounting
ISBN:
9780357233306
Author:
Maloney
Publisher:
Cengage
Cornerstones of Financial Accounting
Cornerstones of Financial Accounting
Accounting
ISBN:
9781337690881
Author:
Jay Rich, Jeff Jones
Publisher:
Cengage Learning
Individual Income Taxes
Individual Income Taxes
Accounting
ISBN:
9780357109731
Author:
Hoffman
Publisher:
CENGAGE LEARNING - CONSIGNMENT